全文获取类型
收费全文 | 139922篇 |
免费 | 14210篇 |
国内免费 | 8207篇 |
专业分类
耳鼻咽喉 | 1088篇 |
儿科学 | 1827篇 |
妇产科学 | 1582篇 |
基础医学 | 21293篇 |
口腔科学 | 2518篇 |
临床医学 | 16611篇 |
内科学 | 18987篇 |
皮肤病学 | 1566篇 |
神经病学 | 6845篇 |
特种医学 | 4982篇 |
外国民族医学 | 65篇 |
外科学 | 13436篇 |
综合类 | 23235篇 |
现状与发展 | 29篇 |
一般理论 | 12篇 |
预防医学 | 9575篇 |
眼科学 | 3421篇 |
药学 | 16361篇 |
119篇 | |
中国医学 | 7747篇 |
肿瘤学 | 11040篇 |
出版年
2024年 | 188篇 |
2023年 | 1981篇 |
2022年 | 3513篇 |
2021年 | 6404篇 |
2020年 | 5252篇 |
2019年 | 4712篇 |
2018年 | 4939篇 |
2017年 | 4536篇 |
2016年 | 4318篇 |
2015年 | 6311篇 |
2014年 | 7813篇 |
2013年 | 7606篇 |
2012年 | 10636篇 |
2011年 | 11283篇 |
2010年 | 7929篇 |
2009年 | 6401篇 |
2008年 | 7708篇 |
2007年 | 7731篇 |
2006年 | 7016篇 |
2005年 | 6354篇 |
2004年 | 4959篇 |
2003年 | 4831篇 |
2002年 | 4105篇 |
2001年 | 3412篇 |
2000年 | 2934篇 |
1999年 | 2589篇 |
1998年 | 1639篇 |
1997年 | 1750篇 |
1996年 | 1225篇 |
1995年 | 1201篇 |
1994年 | 1097篇 |
1993年 | 776篇 |
1992年 | 969篇 |
1991年 | 895篇 |
1990年 | 794篇 |
1989年 | 736篇 |
1988年 | 665篇 |
1987年 | 560篇 |
1986年 | 537篇 |
1985年 | 431篇 |
1984年 | 375篇 |
1983年 | 315篇 |
1982年 | 273篇 |
1981年 | 232篇 |
1980年 | 205篇 |
1979年 | 203篇 |
1978年 | 196篇 |
1977年 | 213篇 |
1976年 | 199篇 |
1974年 | 154篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
Yan Gao MD Yizhen Liu MD PhD Yafei Wang MD Qingyuan Zhang MD Depei Wu MD Xu Ye MD Jianqiu Wu MD Wei Xu MD Jianfeng Zhou MD Yu Yang MD Hong Cen MD Feng Zhang MD Ying Xiang MD Xiaoqiong Tang MD Kaiyang Ding MD JinYing Lin MD Lei Ma MD Shunqing Wang MD Hao Yu MD Yang Zhao MD Bin Song MD Fangfang Lv MD Huiqiang Huang MD 《Cancer》2023,129(4):551-559
32.
The research and development of penicillin started with difficulty before 1949 and achieved certain results. In 1951, after the founding of the People's Republic of China, Zhang Weishen, as the only Chinese scientist who had been trained and worked in a penicillin research and development center in the United States for many years, overcame many difficulties and returned to China. In 1953, with the efforts of Zhang Weishen and his colleagues, China realized the industrialized production of penicillin, alleviating the urgent needs of the masses. Antibiotics has also become the first discipline to achieve major scientific and technological achievements after the founding of the New China. In the mid-1950s, the technical breakthrough in the localization of lactose substitutes marked the localization of the raw materials of the penicillin-producing culture medium, which paved the way for the industrialized production of penicillin with Chinese characteristics. Antibiotics have become one of the most widely used and affordable drugs for hundreds of millions of patients in China, and China has since ended the humiliating history of the “Sick Man of East Asia". 相似文献
33.
34.
35.
36.
目的:通过基层中医费用的发展变化及流向情况分析,研究“十三五”期间北京市基层中医药服务的发展状况。方法:采用基于比例系数的个案库汇总法。结果:“十三五”期间,基层中医药服务能力实现了与卫生系统的协调发展; 社区卫生服务机构是基层中医药服务提供的主体;基层中医药服务主要以提供药品服务为主。结论:北京市应借力发展契机,进一步提升基层医疗卫生机构中医药服务能力;多渠道并进,推动中医门诊部、诊所发展;发展基层中医特色技术服务, 提升基层中医药发展质量。 相似文献
37.
Biaoming Xu Yu Chen Mingjing Peng Jin Hai Zheng Chaohui Zuo 《International journal of cancer. Journal international du cancer》2023,152(2):110-122
Pancreatic cancer (PC) is a cancer of the digestive system, and pancreatic ductal adenocarcinoma (PDAC) accounts for approximately 90% of all PC cases. Exosomes derived from PDAC (PDAC-exosomes) promote PDAC development and metastasis. Exosomes are nanoscale vesicles secreted by most cells, which can carry biologically active molecules and mediate communication and cargo transportation among cells. Recent studies have focused on transforming exosomes into good drug delivery systems (DDSs) to improve the clinical treatment of PDAC. This review considers PDAC as the main research object to introduce the role of PDAC-exosomes in PDAC development and metastasis. This review focuses on the following two themes: (a) the great potential of PDAC-exosomes as new diagnostic markers for PDAC, and (b) the transformation of exosomes into potential DDSs. 相似文献
38.
Qiangsheng He Chongfei Huang Xiwen Qin Yuanyuan Yu Di Tang Junjie Huang Zi Chong Kuo Yuyao Ling Deli Mao Bin Xia Wenjing Li Kuiqing Lu Man Yang Yulong He Wenbo Meng Jinqiu Yuan Yihang Pan 《International journal of cancer. Journal international du cancer》2023,153(5):942-949
Recent epidemiological studies suggested that proton pump inhibitor (PPI) use was associated with an increased risk of biliary tract cancer (BTC), however, confounders were not adequately controlled. Our study aimed to evaluate PPI use and subsequent risk of BTC and its subtypes in three well-established cohorts. We conducted a pooled analysis of the subjects free of cancers in UK Biobank (n = 463 643), Nurses' Health Study (NHS, n = 80 235) and NHS II (n = 95 869). Propensity score weighted Cox models were used to estimate marginal HRs of PPIs use on BTC risk, accounting for potential confounders. We documented 284 BTC cases in UK Biobank (median follow-up: 7.6 years), and 91 cases in NHS and NHS II cohorts (median follow-up: 15.8 years). In UK biobank, PPI users had a 96% higher risk of BTC compared to nonusers in crude model (HR 1.96, 95% CI 1.44-2.66), but the effect was attenuated to null after adjusting for potential confounders (HR 0.95, 95% CI 0.60-1.49). PPI use was not associated with risk of BTC in the pooled analysis of three cohorts (HR 0.93, 95% CI 0.60-1.43). We also observed no associations between PPI use with risk of intrahepatic (HR 1.00, 95% CI 0.49-2.04), extrahepatic bile duct (HR 1.09, 95% CI 0.52-2.27) and gallbladder cancers (HR 0.66, 95% CI 0.26-1.66) in UK Biobank. In summary, regular use of PPIs was not associated with the risk of BTC and its subtypes. 相似文献
39.
40.